J.P. Morgan increased its holdings in INNOVENT BIO (01801) by 58,590 shares, with an approximate price per share of about HK$79.23.

19:22 12/02/2026

On February 6th, J.P. Morgan increased its holdings in Sino Biopharmaceutical (01801) by 585,900 shares, with a price per share of HK$79.232, for a total amount of approximately HK$46.422 million.

According to the latest data from the Hong Kong Stock Exchange, on February 6th, J.P. Morgan increased its holdings of INNOVENT BIO (01801) by 585,900 shares, with an average price of HKD 79.232 per share, totaling approximately HKD 46.42 million. After the increase, the latest number of shares held is approximately 87.2176 million, with a new shareholding ratio of 5.02%.

SINOPEC KANTONS (00934) signs exclusive operating agreement with Caofeidian Port Group.

NOAH HOLDINGS (06686) spent $83,900 to repurchase 35,000 shares on February 11th.

Microsoft Corporation (MSFT.US) reaffirms relationship with OpenAI: pivoting towards AI self-sufficiency and focusing on developing cutting-edge models in-house.

SINOPEC KANTONS (00934) signs exclusive operating agreement with Caofeidian Port Group.

NOAH HOLDINGS (06686) spent $83,900 to repurchase 35,000 shares on February 11th.

Microsoft Corporation (MSFT.US) reaffirms relationship with OpenAI: pivoting towards AI self-sufficiency and focusing on developing cutting-edge models in-house.